Change at the top at Adaptimmune as Noble stands down

Adaptimmune and GSK’s novel T-cell therapy works in solid tu...

Adaptimmune has more good news from its SPEAR T-cell therapy, yesterday unveiling encouraging early results in four patients with myxoid/round cell liposarcoma (MRCLS).

GSK takes option to develop T-cell therapy with Adaptimmune

GlaxoSmithKline has jumped onto the T-cell cancer therapy bandwagon, taking an option with US biotech Adaptimmune to develop a treatment targeting a peptide found on the surface of most can

Adaptimmune revives ovarian cancer trial

T-cell trial will include controversial chemo agent fludarabine.

Adaptimmune progresses T-cell therapy trial

Biotech says "robust" clinical response in early stage trial.

FDA calls for hold on Adaptimmune T-cell trial

Regulator asks for information on trial design.